Core inflation remains elevated and could move higher as Pres. Donald Trump prepares to impose 25% tariffs on imports from Canada and Mexico.
Pharmaceuticals
GLP-1 drugs like Ozempic have potential as treatments beyond diabetes and weight loss, but also pose GI, kidney, and pancreatic risks.
AI systems can optimize drug selection by predicting dosage, safety, and efficacy, potentially reducing clinical trial costs.
AlphaFold accelerates protein modeling, enabling precise drug design and transforming medicine with faster, targeted treatments.
Off-brand versions of Ozempic and other GLP-1 weight loss products are often unregulated, impure, and lack proper dosing instructions.